Application of mouse model for effective evaluation of foot-and-mouth disease vaccine

Vaccine

Volumn 34, Issue 33, 2016, Pages 3731-3737

  Lee, Seo Yong ^a,b   Ko, Mi Kyeong ^a   Lee, Kwang Nyeong ^a   Choi, Joo Hyung ^a   You, Su Hwa ^a   Pyo, Hyun Mi ^a   Lee, Myoung Heon ^a   Kim, Byounghan ^a   Lee, Jong Soo ^b   Park, Jong Hyeon ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Challenge; Evaluation; Foot and mouth disease; Mouse FMD model; Mouse adapted FMDV; Vaccine

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; NONSTRUCTURAL PROTEIN L; NONSTRUCTURAL PROTEIN P2; NONSTRUCTURAL PROTEIN P3; NUCLEOTIDE; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; PROTEIN VP4; STRUCTURAL PROTEIN; STRUCTURAL PROTEIN 2; STRUCTURAL PROTEIN 3; STRUCTURAL PROTEIN 4; UNCLASSIFIED DRUG; INACTIVATED VACCINE; VIRUS VACCINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CODON; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; EPIDEMIC; FEMALE; FETUS; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS A MALAYSIA 97; FOOT AND MOUTH DISEASE VIRUS ASIA1 MOG/2005; FOOT AND MOUTH DISEASE VIRUS O JINCHEON/SKR/2014; GOAT; HUMAN; INFECTION PREVENTION; LD50; MOUSE; MOUSE MODEL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEROTYPE; VACCINATION; VIRUS CULTURE; VIRUS PATHOGENESIS; ANIMAL; C57BL MOUSE; CLASSIFICATION; DISEASE MODEL; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MICE, INBRED C57BL; SEROGROUP; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84990987705     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.06.008     Document Type: Article

References (23)

1. [1] Grubman, M.J., Baxt, B., Foot-and-mouth disease. Clin Microbiol Rev 17 (2004), 465–493.
2. [2] Gibbens, J.C., Sharpe, C.E., Wilesmith, J.W., Mansley, L.M., Michalopoulou, E., Ryan, J.B., et al. Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: the first five months. Vet Rec 149 (2001), 729–743.
3. [3] Knowles, N.J., Samuel, A.R., Davies, P.R., Kitching, R.P., Donaldson, A.I., Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet Rec 148 (2001), 258–259.
4. [4] Park, J.H., Lee, K.N., Ko, Y.J., Kim, S.M., Lee, H.S., Park, J.Y., et al. Outbreaks and diagnosis of foot-and-mouth disease serotype O in the Republic of Korea, April–June 2010. Transbound Emerg Dis 61 (2014), 277–284.
5. [5] Yang, P.C., Chu, R.M., Chung, W.B., Sung, H.T., Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet Rec 145 (1999), 731–734.
6. [6] Bachrach, H.L., Foot-and-mouth disease. Annu Rev Microbiol 22 (1968), 201–244.
7. [7] Domingo, E., Escarmis, C., Baranowski, E., Ruiz-Jarabo, C.M., Carrillo, E., Nunez, J.I., et al. Evolution of foot-and-mouth disease virus. Virus Res 91 (2003), 47–63.
8. [8] Shin, J.H., Sohn, H.J., Choi, K.S., Kwon, B.J., Ko, Y.J., An, D.J., et al. Molecular epidemiological investigation of foot-and-mouth disease virus in Korea in 2000. J Vet Med Sci/Japan Soc Vet Sci 65 (2003), 9–16.
9. [9] Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., Huggins, J., A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 178 (1998), 651–661.
10. [10] Hayashi, K., Iwasaki, Y., Yanagi, K., Herpes simplex virus type 1-induced hydrocephalus in mice. J Virol 57 (1986), 942–951.
11. [11] Huang, K.J., Li, S.Y., Chen, S.C., Liu, H.S., Lin, Y.S., Yeh, T.M., et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 81 (2000), 2177–2182.
12. [12] Wichmann, D., Grone, H.J., Frese, M., Pavlovic, J., Anheier, B., Haller, O., et al. Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice. J Virol 76 (2002), 8890–8899.
13. [13] Habiela, M., Seago, J., Perez-Martin, E., Waters, R., Windsor, M., Salguero, F.J., et al. Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity. J Gen Virol 95 (2014), 2329–2345.
14. [14] Brehm, K.E., Ferris, N.P., Lenk, M., Riebe, R., Haas, B., Highly sensitive fetal goat tongue cell line for detection and isolation of foot-and-mouth disease virus. J Clin Microbiol 47 (2009), 3156–3160.
15. [15] Lee, S.Y., Park, M.E., Kim, R.H., Ko, M.K., Lee, K.N., Kim, S.M., et al. Genetic and immunologic relationships between vaccine and field strains for vaccine selection of type A foot-and-mouth disease virus circulating in East Asia. Vaccine 33 (2015), 664–669.
16. [16] Kim, S.M., Lee, K.N., Lee, S.J., Ko, Y.J., Lee, H.S., Kweon, C.H., et al. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus. Antiviral Res 87 (2010), 307–317.
17. [17] Kim, R.H., Chu, J.Q., Park, J.N., Lee, S.Y., Lee, Y.J., Ko, M.K., et al. Antigenic properties and virulence of foot-and-mouth disease virus rescued from full-length cDNA clone of serotype O, typical vaccine strain. Clin Exp Vacc Res 4 (2015), 114–118.
18. [18] Park, M.E., Lee, S.Y., Kim, R.H., Ko, M.K., Lee, K.N., Kim, S.M., et al. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats. Vaccine 32 (2014), 5221–5227.
19. [19] Charpentier, N., Davila, M., Domingo, E., Escarmis, C., Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. Virology 223 (1996), 10–18.
20. [20] Garcia-Nunez, S., Konig, G., Berinstein, A., Carrillo, E., Differences in the virulence of two strains of foot-and-mouth disease virus serotype A with the same spatiotemporal distribution. Virus Res 147 (2010), 149–152.
21. [21] Fernandez, F.M., Borca, M.V., Sadir, A.M., Fondevila, N., Mayo, J., Schudel, A.A., Foot-and-mouth disease virus (FMDV) experimental infection: susceptibility and immune response of adult mice. Vet Microbiol 12 (1986), 15–24.
22. [22] Salguero, F.J., Sanchez-Martin, M.A., Diaz-San Segundo, F., de Avila, A., Sevilla, N., Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice. Virology 332 (2005), 384–396.
23. [23] Steinberger, J., Skern, T., The leader proteinase of foot-and-mouth disease virus: structure–function relationships in a proteolytic virulence factor. Biol Chem 395 (2014), 1179–1185.